financetom
Business
financetom
/
Business
/
Agilent Technologies Fiscal Q2 Non-GAAP Earnings, Revenue Fall; Full Year Guidance Cut -- Shares Down After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Agilent Technologies Fiscal Q2 Non-GAAP Earnings, Revenue Fall; Full Year Guidance Cut -- Shares Down After Hours
May 29, 2024 2:02 PM

04:40 PM EDT, 05/29/2024 (MT Newswires) -- Agilent Technologies ( A ) reported fiscal Q2 non-GAAP earnings late Wednesday of $1.22 per diluted share, down from $1.27 a year earlier.

Analysts polled by Capital IQ expected $1.19.

Net revenue for the quarter ended April 30 was $1.57 billion, compared with $1.72 billion a year earlier. Analysts surveyed by Capital IQ expected $1.58 billion.

For fiscal Q3, the company said it expects non-GAAP EPS of 1.25 to $1.28 on revenue of $1.54 billion to $1.58 billion. Analysts expect $1.45 EPS and $1.72 billion revenue.

For fiscal 2024, the company now expects non-GAAP EPS of $5.15 to $5.25, down from its previous guidance of $5.44 to $5.55. Analysts expect $5.50.

It now expects fiscal 2024 revenue ranging from $6.42 billion to $6.50 billion, lower than its previous outlook of $6.71 billion to $6.81 billion. Analysts are looking for $6.78 billion.

The company said its board recently approved board a $2.0 billion share repurchase program, and it plans to buy back $750 million of its common stock by the end of the fiscal year.

Shares of the company slumped 14% in recent after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Keensight Capital Acquires Majority Stake in Isto Biologics, a Leading Orthobiologics Player, From Thompson Street Capital Partners
Keensight Capital Acquires Majority Stake in Isto Biologics, a Leading Orthobiologics Player, From Thompson Street Capital Partners
Sep 17, 2025
HOPKINTON, Mass.--(BUSINESS WIRE)-- Keensight Capital (“Keensight”), one of the leading private equity managers dedicated to pan-European Growth Buyout[1] investments, today announced it has agreed to acquire a majority stake in Isto Biologics (“Isto”) from Thompson Street Capital Partners (“TSCP”). TSCP will retain a minority stake, alongside Isto Biologics’ management team. Founded in 2016, Isto Biologics is a regenerative MedTech company...
Security Properties Closes $400.8 Million Acquisition
Security Properties Closes $400.8 Million Acquisition
Sep 17, 2025
The Sale Marks One of the Single Largest Multifamily Transaction in the Seattle Area in 2025 SEATTLE, Sept. 17, 2025 /PRNewswire/ -- Security Properties, the leading real estate investment firm in the Pacific Northwest, has completed one of the largest multifamily acquisitions in the Seattle area so far this year, purchasing a five-property, 903-unit Seattle portfolio from Washington Holdings for $400.8 million....
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
Sep 17, 2025
EMERYVILLE, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation ( XOMA ) , a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, today announced the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of HilleVax, Inc. ( HLVX ) (“HilleVax”) common stock...
I Squared Capital Acquires Majority Stake in ENTEK to Reshore Critical U.S. Battery Manufacturing
I Squared Capital Acquires Majority Stake in ENTEK to Reshore Critical U.S. Battery Manufacturing
Sep 17, 2025
$800 Million Investment Powers America’s First Gigafactory for Lithium-Ion Separators, Strengthening American Supply Chains and Economic Security MIAMI--(BUSINESS WIRE)-- I Squared Capital (“I Squared”), a leading global infrastructure investment manager, today announced it has signed a definitive agreement to acquire a majority equity interest in ENTEK Technology Holdings LLC (“ENTEK”), a leading global manufacturer of battery separators. I Squared’s...
Copyright 2023-2026 - www.financetom.com All Rights Reserved